Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The study should create data for the selection of a clinically relevant endpoint to assess
the potential of Buparid/PARI SINUS to postpone sinus surgery in patients with chronic
Rhinosinusitis.